Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sebaceous carcinoma: evidence-based clinical practice guidelines.
Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw SH, Cartee TV, Chandra S, Cho NL, Choi JN, Council ML, Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim SF, Jiang SB, Kim J, Kuzel TM, Lai SY, Lawrence N, Lee EH, Leitenberger JJ, Maher IA, Mann MW, Minkis K, Mittal BB, Nehal KS, Neuhaus IM, Ozog DM, Petersen B, Rotemberg V, Samant S, Samie FH, Servaes S, Shields CL, Shin TM, Sobanko JF, Somani AK, Stebbins WG, Thomas JR, Thomas VD, Tse DT, Waldman AH, Wong MK, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Reynolds KA, Poon E, Alam M. Owen JL, et al. Among authors: kelm rc. Lancet Oncol. 2019 Dec;20(12):e699-e714. doi: 10.1016/S1470-2045(19)30673-4. Lancet Oncol. 2019. PMID: 31797796 Review.
Sebaceous carcinoma: controversies and their evidence for clinical practice.
Kibbi N, Worley B, Owen JL, Kelm RC, Bichakjian CK, Chandra S, Demirci H, Kim J, Nehal KS, Thomas JR, Poon E, Alam M. Kibbi N, et al. Among authors: kelm rc. Arch Dermatol Res. 2020 Jan;312(1):25-31. doi: 10.1007/s00403-019-01971-4. Epub 2019 Aug 30. Arch Dermatol Res. 2020. PMID: 31471636 Review.
Inflammatory bowel disease events after exposure to interleukin 17 inhibitors secukinumab and ixekizumab: Postmarketing analysis from the RADAR ("Research on Adverse Drug events And Reports") program.
Orrell KA, Murphrey M, Kelm RC, Lee HH, Pease DR, Laumann AE, West DP, Nardone B. Orrell KA, et al. Among authors: kelm rc. J Am Acad Dermatol. 2018 Oct;79(4):777-778. doi: 10.1016/j.jaad.2018.06.024. Epub 2018 Jun 18. J Am Acad Dermatol. 2018. PMID: 29920313 No abstract available.
Age and sex differences for malignant melanoma in the pediatric population-childhood versus adolescence: analysis of current nationwide data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program.
Kelm RC, Ali Y, Orrell K, Rangel SM, Kruse L, Wagner AM, Gerami P, West DP, Nardone B. Kelm RC, et al. J Am Acad Dermatol. 2021 Mar;84(3):862-864. doi: 10.1016/j.jaad.2020.10.050. Epub 2020 Oct 24. J Am Acad Dermatol. 2021. PMID: 33478777 No abstract available.
Utility of platelet-rich plasma in aesthetics.
Kelm RC, Ibrahim O. Kelm RC, et al. Clin Dermatol. 2022 Jan-Feb;40(1):19-28. doi: 10.1016/j.clindermatol.2021.08.007. Epub 2021 Aug 8. Clin Dermatol. 2022. PMID: 35190060
15 results